Cargando…

Non-Alcoholic Fatty Liver Disease among Type-2 Diabetes Mellitus Patients in Abha City, South Western Saudi Arabia

The objective of this study was to determine the prevalence and the factors associated with non-alcoholic fatty liver disease (NAFLD) among type-2 diabetes mellitus (T2DM) patients in Abha City, Southwestern Saudi Arabia. Using a cross-sectional study design, a representative sample of 245 T2DM pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsabaani, Abdullah A., Mahfouz, Ahmed A., Awadalla, Nabil J., Musa, Mustafa Jafar, Al Humayed, Suliman M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266142/
https://www.ncbi.nlm.nih.gov/pubmed/30423871
http://dx.doi.org/10.3390/ijerph15112521
_version_ 1783375771677491200
author Alsabaani, Abdullah A.
Mahfouz, Ahmed A.
Awadalla, Nabil J.
Musa, Mustafa Jafar
Al Humayed, Suliman M.
author_facet Alsabaani, Abdullah A.
Mahfouz, Ahmed A.
Awadalla, Nabil J.
Musa, Mustafa Jafar
Al Humayed, Suliman M.
author_sort Alsabaani, Abdullah A.
collection PubMed
description The objective of this study was to determine the prevalence and the factors associated with non-alcoholic fatty liver disease (NAFLD) among type-2 diabetes mellitus (T2DM) patients in Abha City, Southwestern Saudi Arabia. Using a cross-sectional study design, a representative sample of 245 T2DM patients were recruited from all primary healthcare centers in Abha city. A detailed medical history as well as laboratory investigations were done. NAFLD was diagnosed using abdominal ultrasound examination. The overall prevalence of NAFLD was 72.8% (95% CI: 66.6%–78.1%). In a multivariable regression analysis, the risk of NAFLD was significantly higher among overweight T2DM patients (aOR = 6.112, 95% CI: 1.529–4.432), Obese (aOR = 10.455, 95% CI: 2.645–41.326), with high ALT of more than 12 IU/L (aOR = 2.335, 95% CI: 1.096–5.062), moderate diet-compliant patients (aOR = 2.413, 95% CI: 1.003–5.805) and poor diet-compliant patients (aOR = 6.562, 95% CI: 2.056–20.967). On the other hand, high HDL (high density cholesterol) (in mg/dL) was a protective factor for NAFLD (aOR = 0.044, 95% CI: 0.005–0.365). It was concluded that NAFLD is a common association of T2DM. Increasing BMI (Body mass index), lower HDL level, and poor dietary control are significant factors associated with NAFLD among T2DM patients. Health education to improve dietary control and avoid excessive weight gain, testing for NAFLD among diabetic patients, especially those with abnormal BMI and HDL, are recommended for early detection and to ensure optimal levels of HDL.
format Online
Article
Text
id pubmed-6266142
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62661422018-12-15 Non-Alcoholic Fatty Liver Disease among Type-2 Diabetes Mellitus Patients in Abha City, South Western Saudi Arabia Alsabaani, Abdullah A. Mahfouz, Ahmed A. Awadalla, Nabil J. Musa, Mustafa Jafar Al Humayed, Suliman M. Int J Environ Res Public Health Article The objective of this study was to determine the prevalence and the factors associated with non-alcoholic fatty liver disease (NAFLD) among type-2 diabetes mellitus (T2DM) patients in Abha City, Southwestern Saudi Arabia. Using a cross-sectional study design, a representative sample of 245 T2DM patients were recruited from all primary healthcare centers in Abha city. A detailed medical history as well as laboratory investigations were done. NAFLD was diagnosed using abdominal ultrasound examination. The overall prevalence of NAFLD was 72.8% (95% CI: 66.6%–78.1%). In a multivariable regression analysis, the risk of NAFLD was significantly higher among overweight T2DM patients (aOR = 6.112, 95% CI: 1.529–4.432), Obese (aOR = 10.455, 95% CI: 2.645–41.326), with high ALT of more than 12 IU/L (aOR = 2.335, 95% CI: 1.096–5.062), moderate diet-compliant patients (aOR = 2.413, 95% CI: 1.003–5.805) and poor diet-compliant patients (aOR = 6.562, 95% CI: 2.056–20.967). On the other hand, high HDL (high density cholesterol) (in mg/dL) was a protective factor for NAFLD (aOR = 0.044, 95% CI: 0.005–0.365). It was concluded that NAFLD is a common association of T2DM. Increasing BMI (Body mass index), lower HDL level, and poor dietary control are significant factors associated with NAFLD among T2DM patients. Health education to improve dietary control and avoid excessive weight gain, testing for NAFLD among diabetic patients, especially those with abnormal BMI and HDL, are recommended for early detection and to ensure optimal levels of HDL. MDPI 2018-11-11 2018-11 /pmc/articles/PMC6266142/ /pubmed/30423871 http://dx.doi.org/10.3390/ijerph15112521 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Alsabaani, Abdullah A.
Mahfouz, Ahmed A.
Awadalla, Nabil J.
Musa, Mustafa Jafar
Al Humayed, Suliman M.
Non-Alcoholic Fatty Liver Disease among Type-2 Diabetes Mellitus Patients in Abha City, South Western Saudi Arabia
title Non-Alcoholic Fatty Liver Disease among Type-2 Diabetes Mellitus Patients in Abha City, South Western Saudi Arabia
title_full Non-Alcoholic Fatty Liver Disease among Type-2 Diabetes Mellitus Patients in Abha City, South Western Saudi Arabia
title_fullStr Non-Alcoholic Fatty Liver Disease among Type-2 Diabetes Mellitus Patients in Abha City, South Western Saudi Arabia
title_full_unstemmed Non-Alcoholic Fatty Liver Disease among Type-2 Diabetes Mellitus Patients in Abha City, South Western Saudi Arabia
title_short Non-Alcoholic Fatty Liver Disease among Type-2 Diabetes Mellitus Patients in Abha City, South Western Saudi Arabia
title_sort non-alcoholic fatty liver disease among type-2 diabetes mellitus patients in abha city, south western saudi arabia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266142/
https://www.ncbi.nlm.nih.gov/pubmed/30423871
http://dx.doi.org/10.3390/ijerph15112521
work_keys_str_mv AT alsabaaniabdullaha nonalcoholicfattyliverdiseaseamongtype2diabetesmellituspatientsinabhacitysouthwesternsaudiarabia
AT mahfouzahmeda nonalcoholicfattyliverdiseaseamongtype2diabetesmellituspatientsinabhacitysouthwesternsaudiarabia
AT awadallanabilj nonalcoholicfattyliverdiseaseamongtype2diabetesmellituspatientsinabhacitysouthwesternsaudiarabia
AT musamustafajafar nonalcoholicfattyliverdiseaseamongtype2diabetesmellituspatientsinabhacitysouthwesternsaudiarabia
AT alhumayedsulimanm nonalcoholicfattyliverdiseaseamongtype2diabetesmellituspatientsinabhacitysouthwesternsaudiarabia